W Buczko - Concepedia

Author

W Buczko

Medical University of Białystok

Also Known As

A. Azzadin, BUCZKO, WLODZIMIERZ, W Buczko, W. BUCZKO, W. Buczko, Wtodzimierz Buczko

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Medical University of Białystok Mario Negri Institute for Pharmacological Research AngioDynamics (United States)Jagiellonian University University of Łódź

About

W Buczko is an author at Medical University of Białystok specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	701
2	Health Sciences	5	5	144
3	Natural Sciences	2	2	117
4	Anesthesia	2	2	30
5	Social Sciences	1	1	13

W Buczko

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway J Świȩs, Andrzej Mogielnicki, W Buczko, British Journal of Pharmacology	2007	198
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients Dariusz Pawlak, Krystyna Pawlak, Michał Myśliwiec, International Urology and Nephrology	2001	101
The physiological significance of the alternative pathways of angiotensin II production. Karol Kramkowski, Andrzej Mogielnicki, W Buczko PubMed HypertensionCardiovascular PharmacologyAng IiTranslational MedicineAngiogenesis	2006	96
Kynurenine and its metabolites in the rat with experimental renal insufficiency. Dariusz Pawlak, W Buczko PubMed Peripheral Kyn MetabolismRenal InflammationRenal FunctionExperimental Renal InsufficiencyClinical Chemistry	2001	82
Tryptophan Metabolism via the Kynurenine Pathway in Experimental Chronic Renal Failure Dariusz Pawlak, Piotr Myśliwiec, W Buczko The Nephron journals/Nephron journals	2002	76
HEMOSTASIS, PLATELET FUNCTION AND SEROTONIN IN ACUTE AND CHRONIC RENAL FAILURE Dariusz Pawlak, Krystyna Pawlak, W Buczko, Thrombosis Research ThrombopoiesisClinical DisordersBlood PlateletMedicineKidney Failure	1996	68
EFFECT OF FENFLURAMINE ON 5‐HYDROXYTRYPTAMINE UPTAKE AND RELEASE BY RAT BLOOD PLATELETS W Buczko, Giovanni de Gaetano, Silvio Garattini British Journal of Pharmacology Molecular PharmacologyPharmacological StudyMedicinePhysiologyMonoamine Neurotransmitters	1975	64
Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats. M. Kamińska, Andrzej Mogielnicki, Adrian Stankiewicz, PubMed HypertensionVascular DiseaseAng Ii EffectCardiovascular PharmacologyAng Ii	2005	54
Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats. Karol Kramkowski, Andrzej Mogielnicki, Agnieszka Leszczyńska, PubMed HypertensionCardiovascular PharmacologyPharmacotherapyAng IiInflammation	2010	37
IN FOCUS: A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity – a staphylokinase variant. I. In vitro study Janusz Szemraj, Bogdan Walkowiak, Iwona Kawecka, Journal of Thrombosis and Haemostasis ThrombosisIn FocusBlood PlateletMedicineHematology	2005	36

Page 1